The Discovery of Statins

Cell

Volumn 134, Issue 6, 2008, Pages 903-905

  Stossel, Thomas P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; COLESTYRAMINE; COMPACTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; ML 236A; SIMVASTATIN; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; DIET THERAPY; ENZYME ACTIVITY; ENZYME INHIBITION; GALLSTONE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEART INFARCTION; HEART PROTECTION; HOT FLUSH; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIVER DISEASE; LIVER METABOLISM; LYMPHOMA; MORBIDITY; MORTALITY; MOULD; NONHUMAN; PENICILLIUM CITRINUM; PRIORITY JOURNAL; SECONDARY PREVENTION; SHORT SURVEY;

FUNGI;

EID: 51549087329     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2008.09.008     Document Type: Short Survey

References (15)

1. Bilheimer D., Stone N., and Grundy S. J. Clin. Invest. 64 (1979) 524-533
2. Brown M., and Goldstein J. Arterio 5 Suppl (2004) 13-16
3. Brown M., Faust J., Goldstein J., Kaneko I., and Endo A. J. Biol. Chem. 253 (1978) 1121-1128
4. Endo A., Kuroda M., and Tsujita Y. J. Antibiot. (Tokyo) 29 (1976) 1346-1348
5. Endo A., Kuroda M., and Tanzawa K. FEBS Lett. 72 (1976) 323-326
6. Endo A., Tsujita Y., Kuroda M., and Tanzawa K. Eur. J. Biochem. 77 (1977) 31-36
7. Endo A., Tsujita Y., Kuroda M., and Tanzawa K. Biochim. Biophys. Acta 575 (1979) 266-276
8. Fox K., Steg P., Eagle K., Goodman S., Anderson F., Granger C., Flather M., Budaj A., Quill A., Gore J., et al. JAMA 297 (2007) 1892-1900
9. Fredrickson D., Levy R., and Lees R. N. Engl. J. Med. 276 (1971) 94-103, 148-156, 215-225
10. Goldstein J., and Brown M. Annu. Rev. Biochem. 46 (1977) 897-930
11. Scandinavian Simvastatin Survival Group. Lancet 344 (1994) 1383-1389
12. Steinberg D. The Cholesterol Wars: The Cholesterol Skeptics vs the Preponderance of Evidence (2007), Academic Press-Elsevier, San Diego, CA pp. 1-221
13. Tobert J., Bell G., Birtwell J., James I., Kukovetz W., Prior J., Buntinx A., Holmes I., Chao Y.-S., and Bolognese J. J. Clin. Invest. 69 (1982) 913-919
14. Yamamoto A., Sudo H., and Endo A. Atherosclerosis 35 (1980) 259-266
15. Zycher, B., DiMasi, P., and Mile, C.-P. (2008). The truth about drug innovation: thirty-five summary case histories on private sector contributions to pharmaceutical science. In Medical Progress Reports (New York: Manhattan Institute for Policy Research), pp. 1-46. http://www.manhattan-institute.org/tools/pubs.php.